BACKGROUND AND PURPOSE: Pilomyxoid astrocytoma (PMA) is a recently described tumor that typically occurs in the chiasmatic-hypothalamic region in young children and has unique histopathologic and clinical characteristics. These tumors have been previously diagnosed as pilocytic astrocytoma (PA). PMA appears to have a higher rate of recurrence and CSF dissemination than typical PA. METHODS: We analyzed MR findings in four patients with PMA and compared them with those of typical chiasmatic-hypothalamic PA. RESULTS: MR findings of PMA were chiasmatic or hypothalamic enhancing solid tumor with hydrocephalus, highly homogeneous T2 signal intensity that extended into the deep white and gray matter, and CSF dissemination. CONCLUSION: Larger series are needed before the MR imaging findings of chiasmatic or hypothalamic enhancing solid tumor with hydrocephalus, highly homogeneous T2 signal intensity extending into the deep white and gray matter, and CSF dissemination can be used in the differential diagnosis of such tumors.
BACKGROUND AND PURPOSE:Pilomyxoid astrocytoma (PMA) is a recently described tumor that typically occurs in the chiasmatic-hypothalamic region in young children and has unique histopathologic and clinical characteristics. These tumors have been previously diagnosed as pilocytic astrocytoma (PA). PMA appears to have a higher rate of recurrence and CSF dissemination than typical PA. METHODS: We analyzed MR findings in four patients with PMA and compared them with those of typical chiasmatic-hypothalamic PA. RESULTS: MR findings of PMA were chiasmatic or hypothalamic enhancing solid tumor with hydrocephalus, highly homogeneous T2 signal intensity that extended into the deep white and gray matter, and CSF dissemination. CONCLUSION: Larger series are needed before the MR imaging findings of chiasmatic or hypothalamic enhancing solid tumor with hydrocephalus, highly homogeneous T2 signal intensity extending into the deep white and gray matter, and CSF dissemination can be used in the differential diagnosis of such tumors.
Authors: C E Fuller; B Frankel; M Smith; G Rodziewitz; S K Landas; R Caruso; R Schelper Journal: Clin Neuropathol Date: 2001 Nov-Dec Impact factor: 1.368
Authors: T Tihan; P G Fisher; J L Kepner; C Godfraind; R D McComb; P T Goldthwaite; P C Burger Journal: J Neuropathol Exp Neurol Date: 1999-10 Impact factor: 3.685
Authors: J A Strong; H P Hatten; M T Brown; J F Debatin; H S Friedman; W J Oakes; R Tien Journal: AJR Am J Roentgenol Date: 1993-08 Impact factor: 3.959
Authors: Maria Koutourousiou; Paul A Gardner; Julia K Kofler; Juan C Fernandez-Miranda; Carl H Snyderman; L Dade Lunsford Journal: J Neurol Surg B Skull Base Date: 2012-12-31
Authors: L L Linscott; A G Osborn; S Blaser; M Castillo; R H Hewlett; N Wieselthaler; S S Chin; J Krakenes; G L Hedlund; C L Sutton Journal: AJNR Am J Neuroradiol Date: 2008-08-13 Impact factor: 3.825
Authors: Mohamed A El Beltagy; Mostafa M E Atteya; Alaa El-Haddad; Madiha Awad; Hala Taha; Mohamed Kamal; Sherif Abou El Naga Journal: Childs Nerv Syst Date: 2014-02-05 Impact factor: 1.475